The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity-Reference-Cited by-同舟云学术

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity

Published:2022-01 Issue:1 Volume:7 Page:11-13
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Ibanez Borja,Moreno-Arciniegas Andrea

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference7 articles.

1. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry;Lopez-Sendon;Eur Heart J,2020

2. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity;Galan-Arriola;J Am Coll Cardiol,2019

3. T2 mapping identifies early anthracycline-induced cardiotoxicity in elderly patients with cancer;Martin-Garcia;J Am Coll Cardiol Img,2020

4. Clinical validation of a 3-dimensional ultrafast cardiac magnetic resonance protocol including single breath-hold 3-dimensional sequences;Gómez-Talavera;J Am Coll Cardiol Img,2021

5. Paraoxonase-1 Activity in breast cancer patients treated with doxorubicin with or without trastuzumab;Thompson;J Am Coll Cardiol Basic Trans Science.,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection strategies for anthracycline cardiotoxicity;Basic Research in Cardiology;2024-09-09

2. Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis;Complementary Therapies in Medicine;2024-08

3. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis;Free Radical Biology and Medicine;2023-08